Shjnj Pharmaceutical Technologies Inc.

Mycophenolate mofetil

• Category :

  Intermediates/Pharmaceutical intermediates

• Synonyms :

  4-HEXENOIC ACID,6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-5-ISOBENZOFURANYL)-4-METHYL-,2-(4-MORPHOLINYL)ETHYL ESTER;MMF;2-Morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoate;Mycophenolate Mofetil(MMF);6-[(7-hydroxy-5-methoxy-4-methyl-1-oxo-3h-isobenzofuran-6-yl)]-4-methyl-hex-4-enoic acid 2-morpholinoethyl ester;Macophenolate Mofetil;MycophenolicAcid-2-(4-Morpholinyl)ethylEster;Mycophenolate;2-(morpholin-4-yl)ethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoate;Mycophenelate Mofetil;

• CAS NO :

  115007-34-6

• EC NO :

• Molecular Formula :

  C₂₃H₃₁NO₇

• Molecular Weight :

  433.4947

• Main Specifications :

  USP42

• InChI :

  InChI=1/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3

• Packing :

  10 kg/bag; It can also be packed according to the requirements

• Uses :

  Mycophenolate is used for the prevention of organ transplant rejection. Mycophenolate mofetil is indicated for the prevention of organ transplant rejection in adults and kidney transplantation rejection in children over 2 years; whereas mycophenolate sodi

• Molecular Structure :